A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

CompletedOBSERVATIONAL
Enrollment

1,052

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Chronic Kidney Disease
Trial Locations (43)

14186

Research Site, Stockholm

15401

Research Site, Ferrol

15706

Research Site, Santiago de Compostela

20014

Research Site, Donostia / San Sebastian

20156

Research Site, Milan

25198

Research Site, Lleida

28007

Research Site, Madrid

32771

Research Site, Sanford

36213

Research Site, Vigo

40138

Research Site, Bologna

41124

Research Site, Modena

41950

Research Site, Seville

58185

Research Site, Linköping

77099

Research Site, Houston

78229

Research Site, San Antonio

80138

Research Site, Napoli

92505-3071

Research Site, Riverside

94110-3518

Research Site, San Francisco

33870-1216

Research Site, Sebring

02360

Research Site, Plymouth

11030-3816

Research Site, Manhasset

10461-1900

Research Site, The Bronx

97471-8830

Research Site, Roseburg

79902-4821

Research Site, El Paso

00161

Research Site, Rome

466-8560

Research Site, Nagoya

634-8522

Research Site, Kashihara-shi

701-0192

Research Site, Kurashiki

173-0003

Research Site, Itabashi-Ku

860-8556

Research Site, Kumamoto

700-8558

Research Site, Okayama

545-0051

Research Site, Osaka

08243

Research Site, Manresa

08041

Research Site, Barcelona

222 21

Research Site, Lund

182 57

Research Site, Danderyd

NW3 2QG

Research Site, London

HU3 2JZ

Research Site, Hull

M6 8HD

Research Site, Salford

EC1A 7BE

Research Site, London

NG5 1PB

Research Site, Nottingham

SN15 2SB

Research Site, Chippenham

LS9 7TF

Research Site, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY